Back to Journals » OncoTargets and Therapy » Volume 11

Brevilin A promotes oxidative stress and induces mitochondrial apoptosis in U87 glioblastoma cells

Authors Wang J, Li M, Cui X, Lv D, Jin L, Khan M, Ma T

Received 10 July 2018

Accepted for publication 31 August 2018

Published 16 October 2018 Volume 2018:11 Pages 7031—7040


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 3

Editor who approved publication: Dr Sanjeev Srivastava

Jie Wang,1,2 Miao Li,2 Xiaolin Cui,1 Dongyue Lv,1 Lingling Jin,1 Muhammad Khan,3 Tonghui Ma1

1College of Basic Medical Sciences, Dalian Medical University, Dalian, China; 2Department of Neurology, The China-Japan Union Hospital of Jilin University, Changchun, China; 3Department of Zoology, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan

Background: Sesquiterpene lactones are plant-derived, natural, bioactive molecules often used against inflammatory diseases in traditional Chinese medicines. Recently, sesquiterpene lactones have been reported to exhibit potent anticancer activity. In the present study, we have investigated the anticancer activity of Brevilin A, a sesquiterpene lactone component of Centipeda minima, against U87 glioblastoma cells.
Materials and methods: The cell proliferation was determined by MTT assay. Cell morphological changes were observed by phase-contrast microscopy. Flow cytometry was used to measure apoptosis. Glutathione (GSH), ROS generation, and mitochondrial membrane potential were measured using commercially available kits. The expression of proteins was measured by Western blotting analysis.
Results: Brevilin A inhibited the proliferation of, and induced severe morphological changes and apoptotic cell death in, U87 glioblastoma cells in a dose-dependent manner. Further mechanistic study revealed that Brevilin A induces oxidative stress, as evident from ROS generation, GSH depletion, and increased phosphorylation of stress-activated proteins p38 and JNK. Furthermore, Brevilin A bcl-xl/bak ratio, decreased mitochondrial membrane potential and induced cytochrome c release from mitochondria into cytosol in a dose-dependent manner. Finally, Brevilin A decreased the expression of Xiap and increased the expression of cleaved forms of caspase-9 and -3 and PARP in a dose-dependent manner.
Conclusion: Collective findings demonstrated that Brevilin A is a potent, anticancer, bioactive molecule and it effectively induces apoptosis in U87 glioblastoma cells, which is associated with induction of oxidative stress and mitochondrial dysfunction.

Keywords: Brevilin A, glioblastoma, chemotherapy, apoptosis, oxidative stress, mitochondrial dysfunction

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]